novo nordisk oral glp 1 Nordisk's GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure Novo Nordisk's Wegovy Pill Becomes

This allows it to directly support brain health and cognitive function, including memory and focus

Because of their ability to promote satiety (feeling full) and reduce food intake, GLP-1 drugs have also gained FDA approval for weight loss in individuals who are obese or have certain weight-related conditions

( Epub 2015/07/05 )

(Naltrexone is also used in alcohol use disorder.) But there's currently no other drug on the market that would do what GLP-1 drugs appear to do prevent risk of addiction more generally

We routinely update content to reflect current research and expert advice, provide context (and wit) and ensure our links work

342 , d1309 (2011)